Abstract
Elsewhere in this issue, Kane et al. [1] report the Mayo Clinic experience of patients with both atherosclerotic renovascular disease (ARVD) and heart failure, providing important insights into the epidemiology of this common disease association as well as the benefits of undertaking renal revascularization procedures in improving clinical outcomes.
Original language | English |
---|---|
Pages (from-to) | 661-663 |
Number of pages | 3 |
Journal | Nephrology, Dialysis, Transplantation |
Volume | 25 |
Issue number | 3 |
DOIs |
|
Publication status | Published - 1 Mar 2010 |